Scrip Asks…What Does 2024 Hold for Biopharma?

Jan 2024

James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series.

Summary

Contributor

Meet Professionals with Complementary Expertise in Mergers & Acquisitions

Related Perspectives in Mergers & Acquisitions

Lincoln International adds Carlos Candil as Managing Director

Lincoln International, a global investment banking advisory firm, is pleased to announce that Carlos Candil has joined the London office as a Managing Director in the firm’s Energy, Power &… Read More

Packaging Quarterly Review Q1 2024

Supply chain constraints stemming from COVID-19 triggered significant shifts in demand, and access to, packaging supplies across various industries, as well as inventory management strategies. Over the course of the… Read More

Women’s Wear Daily | The Price of Beauty: How Much Are Investors Willing to Pay?

Originally posted by Women’s Wear Daily on April 12, 2024. Many beauty brands are starting to explore deal options. With several different brands in the same market category, this could… Read More

Lincoln International adds Lewis Gray as Managing Director

Lincoln International, a global investment banking advisory firm, is pleased to announce that Lewis Gray has joined as a Managing Director in the firm’s Business Services Group in London. Lewis… Read More